Category

Electroconvulsive-Therapy
ADHD written on medical clipboard
09
Sep

INTUNIV Attention Deficit Hyperactivity Disorder

Shire pharmaceuticals has announced the release of a new medication for Attention Deficit Hyperactivity Disorder (ADHD). They have received FDA approval to market and sell INTUNIV which is a long acting form of the medication guanfacine. Guanfacine is a medication that is used to treat high blood pressure but has long been used as a...
Read More

Call for more information and daily rates:

(888) 727-0441

Categories

CARF - Commission on Accreditation of Rehabilitation Facilities NATSAP | National Association of Therapeutic Schools and Programs NAADAC newsweek